PitchSend

Investor Presentaiton

Aurora's Path to Profitability NEAR TERM Drive down costs by leveraging massive scale • Protecting against eventual margin compression Leadership in Global Medical Markets Invest heavily in R&D to create optionality Brand building and protection through high-quality product HORIZONTALLY DIVERSIFIED MEDIUM TERM Harvest Canadian market cash flow from near term domestic strategy Leverage R&D work in higher margin products (Vapes, CBD infusions, etc.) Global Medical leading to higher margin sales VERTICALLY INTEGRATED LONG TERM Branded high margin products across both global medical and consumer markets 0 R&D supports product development, brand development, and continued improvement in yields AURORA 20

View entire presentation